China Baoan Group Co Ltd
SZSE:000009
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.2
12.09
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
China Baoan Group Co Ltd
Cost of Revenue
China Baoan Group Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
China Baoan Group Co Ltd
SZSE:000009
|
Cost of Revenue
-¥15.5B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-19%
|
|
|
CITIC Ltd
HKEX:267
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fosun International Ltd
HKEX:656
|
Cost of Revenue
-¥144.8B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-14%
|
|
|
J
|
Jiangsu Yueda Investment Co Ltd
SSE:600805
|
Cost of Revenue
-¥3.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
|
Zhe Jiang Jian Feng Group Co Ltd
SSE:600668
|
Cost of Revenue
-¥2.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-3%
|
|
|
B
|
Beijing Aerospace Changfeng Co Ltd
SSE:600855
|
Cost of Revenue
-¥1B
|
CAGR 3-Years
23%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-6%
|
|
China Baoan Group Co Ltd
Glance View
China Baoan Group Co., Ltd., established in 1983, has evolved into a dynamic conglomerate that seamlessly merges tradition with innovation. Rooted initially in the real estate sector, the company expanded its horizons over the decades, venturing into a diverse array of industries. Today, its portfolio encompasses pharmaceuticals, new materials, and high-technology ventures, each segment contributing its distinct thread to the company's rich tapestry. Real estate remains a foundational pillar of its operations, providing a steady revenue base through the development and management of commercial and residential properties across China. With strategic diversification, the company has maneuvered through economic cycles, skillfully leveraging its core competencies to unlock new growth avenues. Beyond the bricks and mortar, China Baoan's venture into pharmaceuticals and new materials signifies its adaptability and pursuit of future-ready sectors. In the pharmaceutical realm, it channels resources into research and development, producing advanced medical solutions and healthcare products that meet the growing demands of the domestic market. Meanwhile, its development of new materials, particularly in lithium-ion batteries and related technologies, aligns with global transitions towards sustainable energy. This sector not only complements its real estate development by aiding innovation in construction materials but also taps into the burgeoning electric vehicle industry, thus opening new revenue streams. Through this intricate blend of legacy and futurism, China Baoan Group crafts its narrative as a versatile power in China's ever-evolving economic landscape, continually seeking opportunities to enhance its footprint both domestically and abroad.
See Also
What is China Baoan Group Co Ltd's Cost of Revenue?
Cost of Revenue
-15.5B
CNY
Based on the financial report for Sep 30, 2024, China Baoan Group Co Ltd's Cost of Revenue amounts to -15.5B CNY.
What is China Baoan Group Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-19%
Over the last year, the Cost of Revenue growth was 44%. The average annual Cost of Revenue growth rates for China Baoan Group Co Ltd have been -12% over the past three years , -11% over the past five years , and -19% over the past ten years .
You don't have any saved screeners yet
